Form EFFECT FibroBiologics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 21, 2025 |
| Accession Number: | 0001493152-25-002750 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FibroBiologics completes third drug batch for diabetic foot ulcer trial
- ELEKTROS Strengthens Its Commitment to the Future of Electric Vehicle Charging
- MissionIRNewsBreaks – NanoViricides (NYSE American: NNVC) Coverage Initiated With Outperform Rating, $6 Price Target
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
